Key result
External radiotherapy was administered to a 76-year-old patient with an implanted cardioverter defibrillator and breast cancer to test management recommendations in practice.
Why the study?
Patients with implantable cardiac devices receiving radiotherapy face risks of device failure, prompting societal management recommendations that require practical testing.
Case Report (n=1)
This case report illustrates the practical application of medical society recommendations for managing patients with implantable cardioverter defibrillators undergoing external radiotherapy.
Answers are grounded in this paper and cite their sources.
May inform periprocedural ICD management during radiotherapy; extends anecdotal support for guidelines but leaves broader validation open.
Introduction: An ever-growing number of patients with implantable cardiac rhythm devices are treated with radiation therapy for cancer and are therefore at risk of device failure. Several medical societies developed recommendations for the management of such patients. We report the case of a 76-year-old patient with an implanted cardioverter defibrillator, treated with external radiotherapy for breast cancer, to test in practice the recommendations on the management of similar cases.
No takes yet. Share an insight, caveat, or question.
Allouche et al. (2021) conducted a case report in Breast cancer and implanted cardioverter defibrillator (n=1). External radiotherapy was evaluated. External radiotherapy was administered to a 76-year-old patient with an implanted cardioverter defibrillator and breast cancer to test management recommendations in practice.
Synapse has enriched 10 related papers. Consider them for comparative context: